![Thomas Mccarthy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Mccarthy
Fondateur chez
Pathios Therapeutics Ltd.
Profil
Thomas Mccarthy is the founder of Pathios Therapeutics Ltd. (2017, Executive Chairman), Grey Wolf Therapeutics Ltd. (2017, Chairman), and ThirtyFiveBio Ltd. (2021, Executive Chairman).
Current jobs include Chairman at Orbit Discovery Ltd. and Venture Partner at Brandon Capital Partners Pty Ltd. Former jobs include CEO, Director & Managing Director at Spinifex Pharmaceuticals Pty Ltd. (2006-2015) and Vice President-Drug Development at Starpharma Holdings Ltd. Education includes an undergraduate degree from Monash University (1989) and a doctorate from Monash University (1993).
Postes actifs de Thomas Mccarthy
| Sociétés | Poste | Début |
|---|---|---|
Orbit Discovery Ltd.
 Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Develops technology for discovery process and drug development | Président | - |
Grey Wolf Therapeutics Ltd.
 Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops next generation immuno-oncology drugs | Fondateur | 01/01/2017 |
Pathios Therapeutics Ltd.
 Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Fondateur | 01/01/2017 |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 01/01/2015 |
ThirtyFiveBio Ltd.
 ThirtyFiveBio Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for digestive system disorders | Fondateur | 26/01/2021 |
Anciens postes connus de Thomas Mccarthy
| Sociétés | Poste | Fin |
|---|---|---|
Spinifex Pharmaceuticals Pty Ltd.
 Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain | Directeur Général | - |
| STARPHARMA HOLDINGS LIMITED | Corporate Officer/Principal | - |
Formation de Thomas Mccarthy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Starpharma Holdings Ltd.
 Starpharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dendrimer products for pharmaceutical, life science & other applications | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Spinifex Pharmaceuticals Pty Ltd.
Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain | Health Technology |
Orbit Discovery Ltd.
Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Develops technology for discovery process and drug development | Health Technology |
Grey Wolf Therapeutics Ltd.
Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops next generation immuno-oncology drugs | Health Technology |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Health Technology |
ThirtyFiveBio Ltd.
ThirtyFiveBio Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for digestive system disorders | Health Technology |
